Related Experiment Video
Updated: Aug 5, 2026

10:26
A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
Published on: May 19, 2023
Imaging-Based Risk Stratification of IPMN Using a Structured Imaging Score: A Retrospective Proof-of-Concept Study
Stefano Fusco1, Hannes F Digomann2, Sabrina Groß3
1Section of Gastroenterology, Oncology and Palliative Care, Department of Internal Medicine 1, Medical Campus Lake Constance, 88048 Friedrichshafen, Germany.
Current Oncology (Toronto, Ont.)
|July 27, 2026
Summary
The Tübingen Dignity Score (TDS) shows high specificity for intraductal papillary mucinous neoplasms (IPMNs) but lower sensitivity compared to other methods. Further validation is needed for its clinical use in IPMN risk stratification.
Area of Science:
- Gastroenterology
- Radiology
- Oncology
Background:
- Accurate risk stratification of intraductal papillary mucinous neoplasms (IPMNs) is crucial but challenging.
- Established methods for IPMN assessment have limitations in sensitivity and specificity.
Purpose of the Study:
- To evaluate the diagnostic performance of the Tübingen Dignity Score (TDS), an imaging-based scoring system, for IPMN risk stratification.
- To compare the TDS with established methods like MRI assessment and Fukuoka criteria.
Main Methods:
- Retrospective analysis of imaging findings (MRI, CT, ultrasound) in patients with suspected IPMN.
- Application of the Tübingen Dignity Score (TDS) as an imaging-based scoring system.
- Comparison of diagnostic performance against histopathology, MRI, and Fukuoka criteria.
Main Results:
- MRI demonstrated high sensitivity (94.4%) but low specificity (57.1%).
- Fukuoka criteria showed high sensitivity (100%) and specificity (91.3%) with a lower positive predictive value.
- The TDS exhibited high specificity (100%) and positive predictive value, but lower sensitivity (40%).
- A trade-off between sensitivity and specificity was observed across evaluated approaches.
Conclusions:
- The Tübingen Dignity Score (TDS) shows potential as a complementary imaging tool for IPMN risk stratification.
- The TDS may aid clinical decision-making when established criteria are inconclusive.
- External, prospective, multicenter validation is necessary due to study limitations (small sample size, retrospective design).